Adage Capital Partners
CRVO icon

Adage Capital Partners’s CervoMed CRVO Stock Holding History

Adage Capital Partners’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-28,600
Closed -$418K – 895
2024
Q3 		$418K Sell
28,600
-11,433
-29% -$177K ﹤0.01% 819
2024
Q2 		$685K Sell
40,033
-159,314
-80% -$3.48M ﹤0.01% 810
2024
Q1 		$4.64M Hold
199,347
– – 0.01% 704
2023
Q4 		$1.52M Hold
199,347
– – ﹤0.01% 749
2023
Q3 		$921K Buy
+199,347
New +$1M ﹤0.01% 766

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Adage Capital Partners's CRVO Position: Q4 2024 in Review

Adage Capital Partners sold out of CervoMed (CRVO) in Q4 2024, closing a stake of 28,600 shares — an estimated $418K sold.

Adage Capital Partners first reported a position in CRVO in Q3 2023 and held it in 5 quarters. The position peaked at $4.64M in Q1 2024. 49 funds tracked by Wall St. Rank hold CRVO as of Q4 2024.

  • Adage Capital Partners reported no remaining CervoMed position as of Q4 2024 after selling out during the quarter.
  • Adage Capital Partners sold 28,600 CervoMed shares in Q4 2024, an estimated $418K.
  • Adage Capital Partners first reported a position in CervoMed in Q3 2023 and held it in 5 quarters.
  • Adage Capital Partners's CervoMed position peaked at $4.64M in Q1 2024.
  • 49 funds tracked by Wall St. Rank held CervoMed as of Q4 2024.

Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.